Atrovent, Spiriva Safety To Be Tracked In Pharmacy Active Surveillance Pilot

An active drug surveillance system pilot, directed by the Critical Path Institute (C-Path), will track safety and efficacy information for the chronic obstructive pulmonary disorder therapies Atrovent and Spiriva